| ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage S Matsuoka, BA Ballif, A Smogorzewska, ER McDonald III, KE Hurov, ... science 316 (5828), 1160-1166, 2007 | 3542 | 2007 |
| Principles of cancer therapy: oncogene and non-oncogene addiction J Luo, NL Solimini, SJ Elledge Cell 136 (5), 823-837, 2009 | 2214 | 2009 |
| The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini J Debnath, KR Mills, NL Collins, MJ Reginato, SK Muthuswamy, ... Cell 111 (1), 29-40, 2002 | 944 | 2002 |
| Cancer proliferation gene discovery through functional genomics MR Schlabach, J Luo, NL Solimini, G Hu, Q Xu, MZ Li, Z Zhao, ... Science 319 (5863), 620-624, 2008 | 462 | 2008 |
| A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis JD Kessler, KT Kahle, T Sun, KL Meerbrey, MR Schlabach, EM Schmitt, ... Science 335 (6066), 348-353, 2012 | 456 | 2012 |
| Non-oncogene addiction and the stress phenotype of cancer cells NL Solimini, J Luo, SJ Elledge Cell 130 (6), 986-988, 2007 | 450 | 2007 |
| Autoantigen discovery with a synthetic human peptidome HB Larman, Z Zhao, U Laserson, MZ Li, A Ciccia, MAM Gakidis, ... Nature biotechnology 29 (6), 535-541, 2011 | 342 | 2011 |
| Recurrent hemizygous deletions in cancers may optimize proliferative potential NL Solimini, Q Xu, CH Mermel, AC Liang, MR Schlabach, J Luo, ... Science 337 (6090), 104-109, 2012 | 267 | 2012 |
| Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis T Schmelzle, AA Mailleux, M Overholtzer, JS Carroll, NL Solimini, ... Proceedings of the National Academy of Sciences 104 (10), 3787-3792, 2007 | 178 | 2007 |
| G1/S Cell Cycle Arrest Provides Anoikis Resistance through Erk-Mediated Bim Suppression NL Collins, MJ Reginato, JK Paulus, DC Sgroi, J LaBaer, JS Brugge Molecular and cellular biology 25 (12), 5282-5291, 2005 | 157 | 2005 |
| Modulation of paclitaxel resistance by annexin IV in human cancer cell lines E Han, SK Tahir, SP Cherian, N Collins, SC Ng British journal of cancer 83 (1), 83-88, 2000 | 139 | 2000 |
| PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis HB Larman, U Laserson, L Querol, K Verhaeghen, NL Solimini, GJ Xu, ... Journal of autoimmunity 43, 1-9, 2013 | 114 | 2013 |
| Akt and ERK Control the Proliferative Response of Mammary Epithelial Cells to the Growth Factors IGF-1 and EGF Through the Cell Cycle Inhibitor p57Kip2 DT Worster, T Schmelzle, NL Solimini, ES Lightcap, B Millard, GB Mills, ... Science signaling 5 (214), ra19-ra19, 2012 | 92 | 2012 |
| Functional proteomics approach to investigate the biological activities of cDNAs implicated in breast cancer AE Witt, LM Hines, NL Collins, Y Hu, RN Gunawardane, D Moreira, ... Journal of proteome research 5 (3), 599-610, 2006 | 91 | 2006 |
| Psoriasin (S100A7) and calgranulin-B (S100A9) induction is dependent on reactive oxygen species and is downregulated by Bcl-2 and antioxidants H Carlsson, M Yhr, S Petersson, N Collins, K Polyak, C Enerbäck Cancer biology & therapy 4 (9), 998-1005, 2005 | 60 | 2005 |
| Treatment of cancer SJ Elledge, J Luo, M Schlabach, N Solimini US Patent App. 12/865,564, 2011 | 30 | 2011 |
| STOP gene Phactr4 is a tumor suppressor NL Solimini, AC Liang, C Xu, NN Pavlova, Q Xu, T Davoli, MZ Li, ... Proceedings of the National Academy of Sciences 110 (5), E407-E414, 2013 | 25 | 2013 |
| KISS1/KISS1R and breast cancer: metastasis promoter S Guzman, M Brackstone, F Wondisford, AV Babwah, M Bhattacharya Seminars in reproductive medicine 37 (04), 197-206, 2019 | 18 | 2019 |
| Application of a synthetic human proteome to autoantigen discovery through PhIP-Seq HB Larman, Z Zhao, U Laserson, MZ Li, A Ciccia, MAM Gakidis, ... Nature biotechnology 29 (6), 535, 2011 | 9 | 2011 |
| Treatment of cancer SJ Elledge, J Luo, M Schlabach, N Solimini | 2 | 2009 |
